Riociguat - CAS# 625115-55-1 carbazone Formula: C12H12N2

Formula: C12H12N2

47-14)32(43)25(7)49-28

Smiles: CC(C)(C)[C@H](NC(=O)[C@@H](NC)C(C)(C)C1C=CC=CC=1)C(=O)N(C)[C@H](/C=C(\C)/C(O)=O)C(C)C

7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoate

31-21)19(29)13-26/h8-10

Riociguat - CAS# 625115-55-1 carbazone Formula: C12H12N2Riociguat, also known as BAY 63 2521, is a novel drug that is currently in clinical development by Bayer. It is a stimulator of soluble guanylate cyclase (sGC). At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class